Frontiers in Oncology,
Journal Year:
2021,
Volume and Issue:
11
Published: Oct. 18, 2021
In
the
era
of
precision
medicine,
radiation
medicine
is
currently
focused
on
precise
delivery
highly
conformal
treatments.
However,
tremendous
developments
in
targeted
therapy
are
yet
to
fulfill
their
full
promise
and
arguably
have
potential
dramatically
enhance
therapeutic
ratio.
The
increased
ability
molecularly
profile
tumors
both
at
diagnosis
relapse
co-incident
progress
field
radiogenomics
could
potentially
pave
way
for
a
more
personalized
approach
treatment
contrast
current
‘‘one
size
fits
all’’
paradigm.
Few
clinical
trials
date
shown
an
improved
outcome
when
combining
agents
with
therapy,
however,
most
failed
show
benefit,
which
due
limited
preclinical
data.
Several
key
molecular
pathways
theoretically
effect
rationally
either
by
directly
enhancing
tumor
cell
kill
or
indirectly
through
abscopal
combined
novel
immunotherapies.
timing
also
important
determine
greatly
affect
depending
pathway
being
inhibited.
Biomedicine & Pharmacotherapy,
Journal Year:
2023,
Volume and Issue:
163, P. 114822 - 114822
Published: May 3, 2023
Breast
cancer
(BC)
is
the
second
most
fatal
disease
and
prime
cause
of
allied
female
deaths.
BC
caused
by
aberrant
tumor
suppressor
genes
oncogenes
regulated
transcription
factors
(TFs)
like
NF-κB.
NF-κB
a
pro-inflammatory
TF
that
crucially
alters
expressions
various
associated
with
inflammation,
cell
progression,
metastasis,
apoptosis
modulates
network
underlie
tumorigenesis.
Herein,
we
focus
on
signaling
pathways,
its
regulators,
rationale
for
targeting
This
review
also
includes
TFs
maintain
crosstalk
their
roles
in
promoting
angiogenesis
metastasis.
In
addition,
discuss
importance
combination
therapies,
resistance
to
treatment,
potential
novel
therapeutic
strategies
including
nanomedicine
targets
Metabolites,
Journal Year:
2023,
Volume and Issue:
13(4), P. 481 - 481
Published: March 27, 2023
Cancer
is
a
major
cause
of
death
worldwide,
with
multiple
pathophysiological
manifestations.
In
particular,
genetic
abnormalities,
inflammation,
bad
eating
habits,
radiation
exposure,
work
stress,
and
toxin
consumption
have
been
linked
to
cancer
disease
development
progression.
Recently,
natural
bioactive
chemicals
known
as
polyphenols
found
in
plants
were
shown
anticancer
capabilities,
destroying
altered
or
malignant
cells
without
harming
normal
cells.
Flavonoids
demonstrated
antioxidant,
antiviral,
anticancer,
anti-inflammatory
effects.
Flavonoid
type,
bioavailability,
possible
method
action
determine
these
biological
actions.
These
low-cost
pharmaceutical
components
significant
activities
are
beneficial
for
several
chronic
disorders,
including
cancer.
Recent
research
has
focused
primarily
on
isolating,
synthesizing,
studying
the
effects
flavonoids
human
health.
Here
we
attempted
summarize
our
current
knowledge
flavonoids,
focusing
their
mode
better
understand
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: March 6, 2024
Background
Glioblastoma
(GBM),
with
its
high
recurrence
and
mortality
rates,
makes
it
the
deadliest
neurological
malignancy.
Oxidative
phosphorylation
is
a
highly
active
cellular
pathway
in
GBM,
NFYB
tumor-associated
transcription
factor.
Both
are
related
to
mitochondrial
function,
but
studies
on
their
relationship
GBM
at
single-cell
level
still
scarce.
Methods
We
re-analyzed
profiles
of
from
patients
different
subtypes
by
transcriptomic
analysis
further
subdivided
large
population
Glioma
cells
into
subpopulations,
explored
interrelationships
pathways
among
cell
stages
clinical
populations,
investigated
between
factor
key
subpopulations
searching
for
prognostic
genes
NFYB,
verified
experiments.
Results
C5
subpopulation
had
highest
percentage
G2M
staging
rGBM,
which
we
hypothesized
might
be
higher
dividing
proliferating
ability
both
subpopulations.
activity
elevated
subgroup,
suggesting
possible
involvement
proliferation
recurrence,
close
association
function.
also
identified
13
associated
MEM60
may
cause
have
poor
prognosis
promoting
drug
resistance.
Knockdown
was
found
contribute
inhibition
proliferation,
invasion,
migration
cells.
Conclusion
These
findings
help
elucidate
mechanisms
function
progression
establish
new
model
therapeutic
target
based
NFYB.
International Journal of Molecular Medicine,
Journal Year:
2022,
Volume and Issue:
49(5)
Published: March 15, 2022
Radiotherapy
is
an
essential
and
effective
treatment
modality
for
cancer.
Excessive
levels
of
reactive
oxygen
species
(ROS)
induced
by
ionizing
radiation
disrupt
the
redox
homeostasis
lead
to
oxidative
stress
that
may
result
in
cell
death.
However,
tumor
microenvironment
dynamic
responds
radiotherapy
activating
numerous
cellular
signaling
pathways.
By
scavenging
excess
ROS,
activity
endogenous
antioxidant
enzymes
radioresistance
worsen
clinical
outcomes.
To
assess
full
potential
radiotherapy,
it
explore
underlying
mechanisms
target
identification.
The
present
review
article
summarized
recent
data
demonstrating
nuclear
factor‑erythroid
factor
2‑related
2
(Nrf2)
as
a
powerful
transcription
one
major
defense
protect
against
response
radiotherapy;
glutathione
(GSH)
thioredoxin
(Trx)
systems
complement
each
other
are
associated
with
protection
cancer
cells
from
damage.
In
addition,
suggested
dual
targeting
inhibit
GSH
Trx
be
strategy
development
radiosensitive
radioprotective
drugs.
Cells,
Journal Year:
2022,
Volume and Issue:
11(4), P. 649 - 649
Published: Feb. 13, 2022
In
solid
tumours,
cancer
cells
that
undergo
epithelial
mesenchymal
transition
(EMT)
express
characteristic
gene
expression
signatures
promote
invasive
migration
as
well
the
development
of
stemness,
immunosuppression
and
drug/radiotherapy
resistance,
contributing
to
formation
currently
untreatable
metastatic
tumours.
The
traits
associated
with
EMT
can
be
controlled
by
signalling
nodes
at
adhesion
sites
(focal
contacts,
invadopodia
microtentacles)
where
regulation
cell
migration,
cycle
progression
pro-survival
converge.
haematological
ample
evidence
accumulated
during
last
decade
indicates
an
EMT-like
phenotype
is
indicative
poor
disease
prognosis.
However,
this
has
not
been
directly
linked
assembly
specific
forms
adhesions.
current
review
we
discuss
role
in
malignancies
examine
its
possible
link
towards
more
aggressive
these
We
also
known
types
adhesions
formed
speculate
on
their
connection
phenotype.
postulate
understanding
architecture
EMT-related
will
lead
discovery
new
therapeutic
interventions
overcome
resistance
therapies.
International Journal of Molecular Sciences,
Journal Year:
2022,
Volume and Issue:
23(8), P. 4393 - 4393
Published: April 15, 2022
At
present,
cancer
is
one
of
the
leading
causes
death
worldwide.
Treatment
failure
remains
prime
hurdles
in
treatment
due
to
metastatic
nature
cancer.
Techniques
have
been
developed
hinder
growth
tumours
or
at
least
stop
metastasis
process.
In
recent
years,
ultrasound
therapy
combined
with
microbubbles
has
gained
immense
success
treatment.
Ultrasound-stimulated
(USMB)
other
treatments
including
radiation
therapy,
chemotherapy
immunotherapy
demonstrated
potential
improved
outcomes
various
vitro
and
vivo
studies.
Studies
shown
that
low
dose
administered
USMB
can
similar
effects
as
high
therapy.
addition,
use
conjunction
radiotherapy
minimize
toxicity
chemotherapeutic
drugs,
respectively.
this
review,
we
discuss
biophysical
properties
its
applicability
particular,
highlight
important
preclinical
early
clinical
findings
demonstrate
antitumour
effect
combining
modalities
(radiotherapy
chemotherapy).
Our
review
mainly
focuses
on
tumour
vascular
mediated
by
these
therapies.
We
also
several
current
limitations,
addition
ongoing
future
efforts
for
applying
Cancers,
Journal Year:
2023,
Volume and Issue:
15(6), P. 1892 - 1892
Published: March 22, 2023
Radiation
has
been
utilized
for
a
long
time
the
treatment
of
cancer
patients.
However,
radiotherapy
(RT)
many
constraints,
among
which
non-selectivity
is
primary
one.
The
implementation
nanoparticles
(NPs)
with
RT
not
only
localizes
radiation
in
targeted
tissue
but
also
provides
significant
tumoricidal
effect(s)
compared
to
alone.
NPs
can
be
functionalized
both
biomolecules
and
therapeutic
agents,
their
combination
significantly
reduces
side
effects
RT.
NP-based
destroys
cells
through
multiple
mechanisms,
including
ROS
generation,
turn
damages
DNA
other
cellular
organelles,
inhibiting
double-strand
damage-repair
system,
obstructing
cell
cycle,
regulating
tumor
microenvironment,
killing
stem
cells.
Furthermore,
such
combined
treatments
overcome
radioresistance
drug
resistance
chemotherapy.
Additionally,
have
shown
synergistic
benefit(s)
enhanced
window.
phototherapy,
i.e.,
photodynamic
therapy
photothermal
RT,
phototoxicity
offers
excellent
benefits.
Moreover,
using
promise
outcomes
clinical
trials.
Therefore,
extensive
research
this
field
will
pave
way
toward
improved
treatment.
Non-coding RNA Research,
Journal Year:
2024,
Volume and Issue:
9(2), P. 388 - 406
Published: Feb. 1, 2024
Long
noncoding
RNAs
(lncRNAs)
are
RNA
transcripts
longer
than
200
nucleotides
that
do
not
code
for
proteins
but
have
been
linked
to
cancer
development
and
metastasis.
Metastasis-associated
lung
adenocarcinoma
transcript
1
(MALAT-1)
influences
crucial
hallmarks
through
intricate
molecular
mechanisms,
including
proliferation,
invasion,
angiogenesis,
apoptosis,
the
epithelial-mesenchymal
transition
(EMT).
The
current
article
highlights
involvement
of
MALAT-1
in
drug
resistance,
making
it
a
potential
target
overcome
chemotherapy
refractoriness.
It
discusses
impact
on
immunomodulatory
molecules,
such
as
major
histocompatibility
complex
(MHC)
PD-L1,
leading
immune
evasion
hindering
anti-tumor
responses.
also
plays
significant
role
immunology
by
regulating
diverse
cell
populations.
In
summary,
is
versatile
regulator,
influencing
tumorigenesis,
chemoresistance,
immunotherapy
Understanding
its
precise
mechanisms
developing
targeted
therapies,
therapeutic
strategies
targeting
show
promise
improving
treatment
outcomes.
However,
further
research
needed
fully
uncover
biology
translate
these
findings
into
clinical
applications.